Author: Jeff Erez

UBS Financial Services Inc. logo

In September 2018, a former client of UBS Financial Services Inc. settled a FINRA arbitration for $1.5 million for losses sustained from investment in VelocityShares 3x Long Crude ETN and Valeant Pharmaceutical International, Inc. The investor was a client of … Continue reading

Raymond James & Associates, Inc. logo

Erez Law is currently investigating former Raymond James Financial Services financial advisor Steve Reznik (CRD# 1067199) regarding recommendations and/or unauthorized purchases of risky biotech stocks such as: Achaogen, Acadia Pharmaceuticals, Celgene, Clovis, Gilead Sciences, and Ziopharm Oncology. Erez Law is … Continue reading